HEADER IMMUNE SYSTEM 18-MAR-25 9NTT TITLE IDENTIFICATION AND NON-CLINICAL CHARACTERIZATION OF SAR444200, A NOVEL TITLE 2 ANTI-GPC3 T-CELL ENGAGER FOR THE TREATMENT OF GPC3+ SOLID TUMORS CAVEAT 9NTT THR B 110 HAS WRONG CHIRALITY AT ATOM CA RESIDUES ARG A 39 CAVEAT 2 9NTT AND GLY A 59 THAT ARE NEXT TO EACH OTHER IN THE SAMPLE CAVEAT 3 9NTT SEQUENCE ARE NOT PROPERLY LINKED: DISTANCE BETWEEN C AND N CAVEAT 4 9NTT IS 21.14 A. RESIDUES ALA A 114 AND PHE A 115 THAT ARE NEXT CAVEAT 5 9NTT TO EACH OTHER IN THE SAMPLE SEQUENCE ARE NOT PROPERLY CAVEAT 6 9NTT LINKED: DISTANCE BETWEEN C AND N IS 7.92 A. RESIDUES GLY A CAVEAT 7 9NTT 186 AND LEU A 192 THAT ARE NEXT TO EACH OTHER IN THE SAMPLE CAVEAT 8 9NTT SEQUENCE ARE NOT PROPERLY LINKED: DISTANCE BETWEEN C AND N CAVEAT 9 9NTT IS 10.30 A. RESIDUES GLY A 209 AND PHE A 211 THAT ARE NEXT CAVEAT 10 9NTT TO EACH OTHER IN THE SAMPLE SEQUENCE ARE NOT PROPERLY CAVEAT 11 9NTT LINKED: DISTANCE BETWEEN C AND N IS 3.41 A. RESIDUES THR A CAVEAT 12 9NTT 226 AND ILE A 228 THAT ARE NEXT TO EACH OTHER IN THE SAMPLE CAVEAT 13 9NTT SEQUENCE ARE NOT PROPERLY LINKED: DISTANCE BETWEEN C AND N CAVEAT 14 9NTT IS 6.51 A. RESIDUES VAL A 239 AND ASN A 241 THAT ARE NEXT CAVEAT 15 9NTT TO EACH OTHER IN THE SAMPLE SEQUENCE ARE NOT PROPERLY CAVEAT 16 9NTT LINKED: DISTANCE BETWEEN C AND N IS 3.26 A. RESIDUES LYS A CAVEAT 17 9NTT 247 AND SER A 249 THAT ARE NEXT TO EACH OTHER IN THE SAMPLE CAVEAT 18 9NTT SEQUENCE ARE NOT PROPERLY LINKED: DISTANCE BETWEEN C AND N CAVEAT 19 9NTT IS 4.51 A. RESIDUES MET A 310 AND ASP A 315 THAT ARE NEXT CAVEAT 20 9NTT TO EACH OTHER IN THE SAMPLE SEQUENCE ARE NOT PROPERLY CAVEAT 21 9NTT LINKED: DISTANCE BETWEEN C AND N IS 10.84 A. RESIDUES CYS A CAVEAT 22 9NTT 349 AND THR A 383 THAT ARE NEXT TO EACH OTHER IN THE SAMPLE CAVEAT 23 9NTT SEQUENCE ARE NOT PROPERLY LINKED: DISTANCE BETWEEN C AND N CAVEAT 24 9NTT IS 56.56 A. RESIDUES GLN A 434 AND PRO A 457 THAT ARE NEXT CAVEAT 25 9NTT TO EACH OTHER IN THE SAMPLE SEQUENCE ARE NOT PROPERLY CAVEAT 26 9NTT LINKED: DISTANCE BETWEEN C AND N IS 27.52 A. RESIDUES LEU A CAVEAT 27 9NTT 466 AND HIS A 468 THAT ARE NEXT TO EACH OTHER IN THE SAMPLE CAVEAT 28 9NTT SEQUENCE ARE NOT PROPERLY LINKED: DISTANCE BETWEEN C AND N CAVEAT 29 9NTT IS 3.27 A. RESIDUES GLY B 16 AND LEU B 19 THAT ARE NEXT TO CAVEAT 30 9NTT EACH OTHER IN THE SAMPLE SEQUENCE ARE NOT PROPERLY LINKED: CAVEAT 31 9NTT DISTANCE BETWEEN C AND N IS 7.88 A. COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYPICAN-3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GTR2-2,INTESTINAL PROTEIN OCI-5,MXR7; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: A0226018C08; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GPC3, OCI5; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 10 ORGANISM_TAXID: 9844; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ONCOPROTEIN, THERAPEUTIC, T-CELL ENGAGER, IMMUNE SYSTEM EXPDTA ELECTRON MICROSCOPY AUTHOR J.D.BATCHELOR,E.SVIDRITSKIY REVDAT 1 14-JAN-26 9NTT 0 JRNL AUTH P.MEONI,A.P.B.VINTEM,V.F.CORTEZ-RETAMOZO,J.JACOBS, JRNL AUTH 2 E.DE TAVERNIER,P.FIORENTINI,D.VAN HOORICK,J.D.BATCHELOR, JRNL AUTH 3 E.SVIDRITSKIY,Y.QIU,E.DEJONCKHEERE,A.LI,L.I.PAO,M.A.BUYSE JRNL TITL IDENTIFICATION AND NON-CLINICAL CHARACTERIZATION OF JRNL TITL 2 SAR444200, A NOVEL ANTI-GPC3 NANOBODY® T-CELL ENGAGER, JRNL TITL 3 FOR THE TREATMENT OF GPC3+ SOLID TUMORS. JRNL REF MOL.CANCER THER. 2025 JRNL REFN ESSN 1538-8514 JRNL PMID 41041827 JRNL DOI 10.1158/1535-7163.MCT-24-1049 REMARK 2 REMARK 2 RESOLUTION. 7.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 7.450 REMARK 3 NUMBER OF PARTICLES : 27317 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9NTT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAR-25. REMARK 100 THE DEPOSITION ID IS D_1000294088. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : 2D ARRAY REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : GPC3 A0226018C08 COMPLEX; GPC3; REMARK 245 A0226018C08 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 8000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS B 129 REMARK 465 HIS B 130 REMARK 465 HIS B 131 REMARK 465 HIS B 132 REMARK 465 HIS B 133 REMARK 465 HIS B 134 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 39 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 80 CG CD CE NZ REMARK 470 LEU A 192 CG CD1 CD2 REMARK 470 ASP A 193 CG OD1 OD2 REMARK 470 LYS A 221 CG CD CE NZ REMARK 470 LYS A 247 CG CD CE NZ REMARK 470 LYS A 336 CG CD CE NZ REMARK 470 LYS A 347 CG CD CE NZ REMARK 470 ARG A 389 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 431 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 75 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG B 80 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG B 109 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 36 -148.37 -89.04 REMARK 500 SER A 60 125.91 -173.53 REMARK 500 ASP A 61 40.75 -144.79 REMARK 500 VAL A 64 -61.61 -135.87 REMARK 500 GLN A 426 -19.93 -151.54 REMARK 500 SER A 433 -84.42 -95.82 REMARK 500 THR A 475 2.06 -69.16 REMARK 500 SER B 93 75.70 45.31 REMARK 500 ARG B 111B -50.24 63.72 REMARK 500 PRO B 112A 32.09 -81.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG B 68 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-49762 RELATED DB: EMDB REMARK 900 IDENTIFICATION AND NON-CLINICAL CHARACTERIZATION OF SAR444200, A REMARK 900 NOVEL ANTI-GPC3 T-CELL ENGAGER FOR THE TREATMENT OF GPC3+ SOLID REMARK 900 TUMORS DBREF 9NTT A 38 477 UNP P51654 GPC3_HUMAN 57 477 DBREF 9NTT B 1 134 PDB 9NTT 9NTT 1 134 SEQADV 9NTT CYS A 35 UNP P51654 EXPRESSION TAG SEQADV 9NTT HIS A 36 UNP P51654 EXPRESSION TAG SEQADV 9NTT GLN A 37 UNP P51654 EXPRESSION TAG SEQADV 9NTT ARG A 39 UNP P51654 PRO 58 CONFLICT SEQADV 9NTT A UNP P51654 LEU 187 DELETION SEQADV 9NTT A UNP P51654 PRO 188 DELETION SEQADV 9NTT A UNP P51654 ASP 189 DELETION SEQADV 9NTT A UNP P51654 SER 190 DELETION SEQADV 9NTT A UNP P51654 ALA 191 DELETION SEQADV 9NTT A UNP P51654 ASN 210 DELETION SEQADV 9NTT A UNP P51654 ARG 227 DELETION SEQADV 9NTT A UNP P51654 ILE 240 DELETION SEQADV 9NTT A UNP P51654 PHE 248 DELETION SEQADV 9NTT A UNP P51654 TYR 311 DELETION SEQADV 9NTT A UNP P51654 ARG 312 DELETION SEQADV 9NTT A UNP P51654 ILE 313 DELETION SEQADV 9NTT A UNP P51654 TYR 314 DELETION SEQADV 9NTT A UNP P51654 ALA 350 DELETION SEQADV 9NTT A UNP P51654 HIS 351 DELETION SEQADV 9NTT A UNP P51654 SER 352 DELETION SEQADV 9NTT A UNP P51654 GLN 353 DELETION SEQADV 9NTT A UNP P51654 GLN 354 DELETION SEQADV 9NTT A UNP P51654 ARG 355 DELETION SEQADV 9NTT A UNP P51654 GLN 356 DELETION SEQADV 9NTT A UNP P51654 TYR 357 DELETION SEQADV 9NTT A UNP P51654 ARG 358 DELETION SEQADV 9NTT A UNP P51654 SER 359 DELETION SEQADV 9NTT A UNP P51654 ALA 360 DELETION SEQADV 9NTT A UNP P51654 TYR 361 DELETION SEQADV 9NTT A UNP P51654 TYR 362 DELETION SEQADV 9NTT A UNP P51654 PRO 363 DELETION SEQADV 9NTT A UNP P51654 GLU 364 DELETION SEQADV 9NTT A UNP P51654 ASP 365 DELETION SEQADV 9NTT A UNP P51654 LEU 366 DELETION SEQADV 9NTT A UNP P51654 PHE 367 DELETION SEQADV 9NTT A UNP P51654 ILE 368 DELETION SEQADV 9NTT A UNP P51654 ASP 369 DELETION SEQADV 9NTT A UNP P51654 LYS 370 DELETION SEQADV 9NTT A UNP P51654 LYS 371 DELETION SEQADV 9NTT A UNP P51654 VAL 372 DELETION SEQADV 9NTT A UNP P51654 LEU 373 DELETION SEQADV 9NTT A UNP P51654 LYS 374 DELETION SEQADV 9NTT A UNP P51654 VAL 375 DELETION SEQADV 9NTT A UNP P51654 ALA 376 DELETION SEQADV 9NTT A UNP P51654 HIS 377 DELETION SEQADV 9NTT A UNP P51654 VAL 378 DELETION SEQADV 9NTT A UNP P51654 GLU 379 DELETION SEQADV 9NTT A UNP P51654 HIS 380 DELETION SEQADV 9NTT A UNP P51654 GLU 381 DELETION SEQADV 9NTT A UNP P51654 GLU 382 DELETION SEQADV 9NTT A UNP P51654 LYS 435 DELETION SEQADV 9NTT A UNP P51654 ALA 436 DELETION SEQADV 9NTT A UNP P51654 ALA 437 DELETION SEQADV 9NTT A UNP P51654 ARG 438 DELETION SEQADV 9NTT A UNP P51654 ASN 439 DELETION SEQADV 9NTT A UNP P51654 GLY 440 DELETION SEQADV 9NTT A UNP P51654 MET 441 DELETION SEQADV 9NTT A UNP P51654 LYS 442 DELETION SEQADV 9NTT A UNP P51654 ASN 443 DELETION SEQADV 9NTT A UNP P51654 GLN 444 DELETION SEQADV 9NTT A UNP P51654 PHE 445 DELETION SEQADV 9NTT A UNP P51654 ASN 446 DELETION SEQADV 9NTT A UNP P51654 LEU 447 DELETION SEQADV 9NTT A UNP P51654 HIS 448 DELETION SEQADV 9NTT A UNP P51654 GLU 449 DELETION SEQADV 9NTT A UNP P51654 LEU 450 DELETION SEQADV 9NTT A UNP P51654 LYS 451 DELETION SEQADV 9NTT A UNP P51654 MET 452 DELETION SEQADV 9NTT A UNP P51654 LYS 453 DELETION SEQADV 9NTT A UNP P51654 GLY 454 DELETION SEQADV 9NTT A UNP P51654 PRO 455 DELETION SEQADV 9NTT A UNP P51654 GLU 456 DELETION SEQADV 9NTT A UNP P51654 LYS 467 DELETION SEQRES 1 A 355 CYS HIS GLN VAL ARG GLY SER ASP LEU GLN VAL CYS LEU SEQRES 2 A 355 PRO LYS GLY PRO THR CYS CYS SER ARG LYS MET GLU GLU SEQRES 3 A 355 LYS TYR GLN LEU THR ALA ARG LEU ASN MET GLU GLN LEU SEQRES 4 A 355 LEU GLN SER ALA SER MET GLU LEU LYS PHE LEU ILE ILE SEQRES 5 A 355 GLN ASN ALA ALA VAL PHE GLN GLU ALA PHE GLU ILE VAL SEQRES 6 A 355 VAL ARG HIS ALA LYS ASN TYR THR ASN ALA MET PHE LYS SEQRES 7 A 355 ASN ASN TYR PRO SER LEU THR PRO GLN ALA PHE GLU PHE SEQRES 8 A 355 VAL GLY GLU PHE PHE THR ASP VAL SER LEU TYR ILE LEU SEQRES 9 A 355 GLY SER ASP ILE ASN VAL ASP ASP MET VAL ASN GLU LEU SEQRES 10 A 355 PHE ASP SER LEU PHE PRO VAL ILE TYR THR GLN LEU MET SEQRES 11 A 355 ASN PRO GLY LEU ASP ILE ASN GLU CYS LEU ARG GLY ALA SEQRES 12 A 355 ARG ARG ASP LEU LYS VAL PHE GLY PHE PRO LYS LEU ILE SEQRES 13 A 355 MET THR GLN VAL SER LYS SER LEU GLN VAL THR ILE PHE SEQRES 14 A 355 LEU GLN ALA LEU ASN LEU GLY ILE GLU VAL ASN THR THR SEQRES 15 A 355 ASP HIS LEU LYS SER LYS ASP CYS GLY ARG MET LEU THR SEQRES 16 A 355 ARG MET TRP TYR CYS SER TYR CYS GLN GLY LEU MET MET SEQRES 17 A 355 VAL LYS PRO CYS GLY GLY TYR CYS ASN VAL VAL MET GLN SEQRES 18 A 355 GLY CYS MET ALA GLY VAL VAL GLU ILE ASP LYS TYR TRP SEQRES 19 A 355 ARG GLU TYR ILE LEU SER LEU GLU GLU LEU VAL ASN GLY SEQRES 20 A 355 MET ASP MET GLU ASN VAL LEU LEU GLY LEU PHE SER THR SEQRES 21 A 355 ILE HIS ASP SER ILE GLN TYR VAL GLN LYS ASN ALA GLY SEQRES 22 A 355 LYS LEU THR THR THR ILE GLY LYS LEU CYS THR LEU SER SEQRES 23 A 355 SER ARG ARG ARG GLU LEU ILE GLN LYS LEU LYS SER PHE SEQRES 24 A 355 ILE SER PHE TYR SER ALA LEU PRO GLY TYR ILE CYS SER SEQRES 25 A 355 HIS SER PRO VAL ALA GLU ASN ASP THR LEU CYS TRP ASN SEQRES 26 A 355 GLY GLN GLU LEU VAL GLU ARG TYR SER GLN PRO VAL VAL SEQRES 27 A 355 SER GLN ILE ILE ASP LYS LEU HIS ILE ASN GLN LEU LEU SEQRES 28 A 355 ARG THR MET SER SEQRES 1 B 127 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 B 127 PRO GLY LEU ARG LEU SER CYS VAL ALA SER GLY PHE THR SEQRES 3 B 127 PHE SER SER PHE ALA MET THR TRP VAL ARG ARG PRO PRO SEQRES 4 B 127 GLY LYS GLY LEU GLU TRP VAL ALA THR ILE THR ASN GLY SEQRES 5 B 127 GLY VAL THR SER TYR ARG ASP SER VAL LYS GLY ARG PHE SEQRES 6 B 127 THR ILE SER ARG ASP ASN ALA LYS ASN THR LEU TYR LEU SEQRES 7 B 127 GLU MET THR SER LEU ASN PRO GLU ASP THR ALA VAL TYR SEQRES 8 B 127 ILE CYS ALA ASN ALA ARG ARG THR GLY PRO ARG ALA PRO SEQRES 9 B 127 THR ASP ILE GLY SER TYR ARG GLY GLN GLY THR LEU VAL SEQRES 10 B 127 THR VAL SER SER HIS HIS HIS HIS HIS HIS HET NAG A 501 14 HET NAG A 502 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 2(C8 H15 N O6) HELIX 1 AA1 SER A 74 ALA A 114 1 41 HELIX 2 AA2 GLU A 116 TYR A 134 1 19 HELIX 3 AA3 PRO A 135 THR A 138 5 4 HELIX 4 AA4 PRO A 139 LEU A 157 1 19 HELIX 5 AA5 ASN A 162 LEU A 182 1 21 HELIX 6 AA6 ILE A 194 LEU A 205 1 12 HELIX 7 AA7 PRO A 212 THR A 226 1 15 HELIX 8 AA8 PHE A 229 VAL A 239 1 11 HELIX 9 AA9 ASN A 241 LEU A 246 5 6 HELIX 10 AB1 LYS A 250 TYR A 261 1 12 HELIX 11 AB2 TYR A 261 GLN A 266 1 6 HELIX 12 AB3 CYS A 274 MET A 286 1 13 HELIX 13 AB4 MET A 286 GLU A 291 1 6 HELIX 14 AB5 GLU A 291 MET A 310 1 20 HELIX 15 AB6 MET A 316 GLY A 322 1 7 HELIX 16 AB7 GLY A 322 LYS A 336 1 15 HELIX 17 AB8 ASN A 337 CYS A 349 1 13 HELIX 18 AB9 LEU A 384 SER A 397 1 14 HELIX 19 AC1 ALA A 404 HIS A 412 1 9 HELIX 20 AC2 VAL A 458 LEU A 466 1 9 HELIX 21 AC3 ILE A 469 THR A 475 1 7 HELIX 22 AC4 ASP B 69 LYS B 72 5 4 HELIX 23 AC5 ASN B 95 THR B 99 5 5 SHEET 1 AA1 2 THR A 420 TRP A 423 0 SHEET 2 AA1 2 LEU A 428 ARG A 431 -1 O VAL A 429 N CYS A 422 SHEET 1 AA2 4 GLN B 3 SER B 7 0 SHEET 2 AA2 4 ARG B 20 SER B 26 -1 O SER B 26 N GLN B 3 SHEET 3 AA2 4 THR B 86 MET B 91 -1 O LEU B 87 N CYS B 23 SHEET 4 AA2 4 PHE B 76 ASP B 81 -1 N SER B 79 O TYR B 88 SHEET 1 AA3 6 GLY B 11 VAL B 13 0 SHEET 2 AA3 6 THR B 122 VAL B 126 1 O LEU B 123 N GLY B 11 SHEET 3 AA3 6 ALA B 100 ARG B 109 -1 N TYR B 102 O THR B 122 SHEET 4 AA3 6 ALA B 38 ARG B 44 -1 N ARG B 44 O VAL B 101 SHEET 5 AA3 6 GLU B 51 ILE B 56 -1 O ILE B 56 N MET B 39 SHEET 6 AA3 6 THR B 65 TYR B 67 -1 O SER B 66 N THR B 55 SHEET 1 AA4 4 GLY B 11 VAL B 13 0 SHEET 2 AA4 4 THR B 122 VAL B 126 1 O LEU B 123 N GLY B 11 SHEET 3 AA4 4 ALA B 100 ARG B 109 -1 N TYR B 102 O THR B 122 SHEET 4 AA4 4 ASP B 113 ARG B 118 -1 O SER B 116 N ASN B 106 SSBOND 1 CYS A 35 CYS A 72 1555 1555 2.03 SSBOND 2 CYS A 65 CYS A 262 1555 1555 2.03 SSBOND 3 CYS A 73 CYS A 265 1555 1555 2.03 SSBOND 4 CYS A 197 CYS A 349 1555 1555 2.03 SSBOND 5 CYS A 252 CYS A 285 1555 1555 2.03 SSBOND 6 CYS A 274 CYS A 422 1555 1555 2.03 SSBOND 7 CYS A 278 CYS A 410 1555 1555 2.03 SSBOND 8 CYS B 23 CYS B 104 1555 1555 2.03 LINK ND2 ASN A 124 C1 NAG A 502 1555 1555 1.44 CISPEP 1 THR A 138 PRO A 139 0 4.72 CISPEP 2 THR B 110 GLY B 111 0 -11.10 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 TER 2781 SER A 477 TER 4599 SER B 128 HETATM 4600 C1 NAG A 501 165.470 164.125 163.558 1.00 76.14 C0 HETATM 4601 C2 NAG A 501 165.537 163.336 164.867 1.00 78.52 C0 HETATM 4602 C3 NAG A 501 165.195 161.870 164.623 1.00 78.67 C0 HETATM 4603 C4 NAG A 501 163.859 161.747 163.904 1.00 86.64 C0 HETATM 4604 C5 NAG A 501 163.877 162.577 162.628 1.00 84.84 C0 HETATM 4605 C6 NAG A 501 162.548 162.588 161.912 1.00 94.64 C0 HETATM 4606 C7 NAG A 501 167.148 164.401 166.385 1.00 87.57 C0 HETATM 4607 C8 NAG A 501 168.548 164.378 166.918 1.00 83.98 C0 HETATM 4608 N2 NAG A 501 166.846 163.459 165.485 1.00 77.99 N0 HETATM 4609 O3 NAG A 501 165.139 161.185 165.869 1.00 76.08 O0 HETATM 4610 O4 NAG A 501 163.599 160.384 163.582 1.00 85.24 O0 HETATM 4611 O5 NAG A 501 164.187 163.942 162.946 1.00 79.33 O0 HETATM 4612 O6 NAG A 501 161.755 163.703 162.294 1.00124.81 O0 HETATM 4613 O7 NAG A 501 166.327 165.240 166.747 1.00 92.23 O0 HETATM 4614 C1 NAG A 502 181.128 161.885 193.270 1.00160.99 C0 HETATM 4615 C2 NAG A 502 181.637 160.481 193.528 1.00172.50 C0 HETATM 4616 C3 NAG A 502 181.101 159.539 192.462 1.00178.85 C0 HETATM 4617 C4 NAG A 502 179.583 159.547 192.521 1.00181.72 C0 HETATM 4618 C5 NAG A 502 179.055 160.968 192.340 1.00184.05 C0 HETATM 4619 C6 NAG A 502 177.564 161.059 192.579 1.00182.48 C0 HETATM 4620 C7 NAG A 502 183.701 159.955 194.719 1.00159.95 C0 HETATM 4621 C8 NAG A 502 182.821 159.588 195.857 1.00162.91 C0 HETATM 4622 N2 NAG A 502 183.083 160.398 193.626 1.00165.98 N0 HETATM 4623 O3 NAG A 502 181.613 158.229 192.681 1.00192.68 O0 HETATM 4624 O4 NAG A 502 179.045 158.720 191.497 1.00195.79 O0 HETATM 4625 O5 NAG A 502 179.677 161.880 193.267 1.00176.98 O0 HETATM 4626 O6 NAG A 502 176.850 160.180 191.722 1.00172.69 O0 HETATM 4627 O7 NAG A 502 184.915 159.866 194.784 1.00173.02 O0 CONECT 6 133 CONECT 85 1578 CONECT 133 6 CONECT 139 1602 CONECT 554 4614 CONECT 1095 2209 CONECT 1489 1743 CONECT 1578 85 CONECT 1602 139 CONECT 1668 2520 CONECT 1694 2433 CONECT 1743 1489 CONECT 2209 1095 CONECT 2433 1694 CONECT 2520 1668 CONECT 3065 4189 CONECT 4189 3065 CONECT 4600 4601 4611 CONECT 4601 4600 4602 4608 CONECT 4602 4601 4603 4609 CONECT 4603 4602 4604 4610 CONECT 4604 4603 4605 4611 CONECT 4605 4604 4612 CONECT 4606 4607 4608 4613 CONECT 4607 4606 CONECT 4608 4601 4606 CONECT 4609 4602 CONECT 4610 4603 CONECT 4611 4600 4604 CONECT 4612 4605 CONECT 4613 4606 CONECT 4614 554 4615 4625 CONECT 4615 4614 4616 4622 CONECT 4616 4615 4617 4623 CONECT 4617 4616 4618 4624 CONECT 4618 4617 4619 4625 CONECT 4619 4618 4626 CONECT 4620 4621 4622 4627 CONECT 4621 4620 CONECT 4622 4615 4620 CONECT 4623 4616 CONECT 4624 4617 CONECT 4625 4614 4618 CONECT 4626 4619 CONECT 4627 4620 MASTER 199 0 2 23 16 0 0 6 3719 2 45 38 END